Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Mesothelioma

Our plain-English summary of Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Mesothelioma, by A.A. Sandberg, J.A. Bridge (Cancer Genetics and Cytogenetics, 2001).

The study

• Authors: A.A. Sandberg, J.A. Bridge
• Journal: Cancer Genetics and Cytogenetics
• Published: 2001;127(2):93-110
• Type of article: Review
• Cited by: 46 articles, as counted by NIH iCite
• Read it: PubMed · Publisher

In plain English

The text supplied for this record is not the cited article. The citation is a 2001 review by Sandberg and Bridge on the cytogenetics and molecular genetics of mesothelioma, published in Cancer Genetics and Cytogenetics. The supplied text is a later book chapter, 'Cytogenetics and Molecular Genetics of Soft Tissue Tumors and Bone Tumors' by A.A. Sandberg. It was written mainly for radiologists, and it lists the cited mesothelioma article among its references. Because the cited article itself is missing, this summary cannot report that article's methods, findings or conclusions. The chapter is a general overview of chromosome changes across many bone and soft tissue tumors and does not discuss asbestos. Outside its reference list, it mentions mesothelioma only twice. One is a single table entry listing deletions on chromosome arms 1p and 9p and inactivation of the BCL10 and CDKN2A genes as recurrent but not specific changes. The other is a remark that a translocation typical of synovial sarcoma helps distinguish that tumor from mesothelioma. These points come from the chapter, not from the cited article. The original article is needed before this record can be summarized.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: Cannot be determined for the cited article. The supplied text is a narrative book chapter giving an overview of genetic changes in bone and soft tissue tumors.
• Main results:
  • In the supplied chapter (not the cited article), a table of recurrent but non-specific chromosome changes lists, for mesothelioma, del(1p) and del(9p), with BCL10 inactivation and CDKN2A inactivation as molecular findings.
  • In the supplied chapter (not the cited article), the synovial sarcoma translocation t(X;18) is described as helping to distinguish synovial sarcoma from tumors including mesothelioma.

Topics

The National Library of Medicine indexes this study under subjects our site covers: Mesothelioma.

Medical terms in this study, explained in our Lexicon: Mesothelioma.

Related studies

• Expression of E-cadherin in bone and soft tissue sarcomas: a possible role in epithelial differentiation — H. Sato, T. Hasegawa, et al. (1999)
• From morphological to molecular diagnosis of soft tissue tumors — M. Miettinen (2006)
• Application of markers in the diagnosis of soft tissue tumours — P.J. Roholl, A.S. De Jong, et al. (1985)
• The marriage of cytology and cytogenetics — P. Dal Cin, X. Qian, et al. (2013)
• Pericardial synovial sarcoma, a potential for misdiagnosis: clinicopathologic and molecular cytogenetic analysis of three cases with literature review — Y. Cheng, W. Sheng, et al. (2012)
• Cytogenetic and molecular genetic changes in malignant mesothelioma — M. Musti, E. Kettunen, et al. (2006)

Browse more research in Cancer Genetics and Cytogenetics, or return to medical research.